PSYCHOGENIC NONEPILEPTIC SEIZURES FOLLOWING COVID 19 VACCINE: A REPORT OF TWO CASES IN COLOMBIA

Author:

Cardona Moica Sandra Marcela,Montaño Lozada Juan Manuel,Villalobos-Comas Julio Cesar,Castillo-Támara Edgard Eliud

Abstract

The novel coronavirus SARS-CoV-2 has caused the death of more than 5 million of people worldwide. Vaccination is the best strategy for controlling the pandemic with an estimated of more that 4 million of people completely vaccinated. The reported adverse events secondary to vaccines against SARS-CoV-2 are mainly mild and moderate, however, there are raising concerns about more severe and long-term outcomes, as well as neurological complications due to the vaccine. We present two cases of psychogenic non epileptiform seizures (PNES) in Colombian female patients, following vaccination against Covid-19. There is no evidence of similar adverse reactions reported on the literature and thus, we decided to report these events in order to help clinicians in recognizing early and properly all the possible neurological manifestations related to this novel approach, that aimes to eradicate the viruses which has come along with worldwide devastating consequences in terms of health and social issues.

Publisher

Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez

Subject

Neurology (clinical),Neurology

Reference16 articles.

1. Bibliography

2. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. febrero de 2020;395(10223):497-506.

3. Spikevax F. SUMMARY OF INSTRUCTIONS FOR COVID-19 VACCINATION PROVIDERS. :35. Healthcare Providers for 12 years of age and older, purple cap (must dilute) 01312022.pdf.

4. download.pdf [Internet]. [citado 27 de febrero de 2022]. Disponible en: https://www.fda.gov/media/146304/download

5. Jackson LA, Anderson EJ, Rouphael NG, Roberts PC, Makhene M, Coler RN, et al. An mRNA Vaccine against SARS-CoV-2 — Preliminary Report. N Engl J Med. 14 de julio de 2020;NEJMoa2022483.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3